Unruptured intracranial aneurysms: Detection and management

Journal of Neuroradiology

Volumn 30, Issue 5, 2003, Pages 336-350

  White, P M ^a   Wardlaw, J M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

CT Angiography; Magnetic Resonance Angiography; Screening; Unruptured intracranial aneurysm

Indexed keywords

GADOLINIUM;

BLOOD VESSEL DIAMETER; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; HUMAN; IMAGE ANALYSIS; INTRACRANIAL ANEURYSM; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MASS SCREENING; NEUROPATHOLOGY; NEUROSURGERY; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; SURGICAL TECHNIQUE;

ANEURYSM, RUPTURED; HUMANS; INTRACRANIAL ANEURYSM; RISK FACTORS;

EID: 0347512149     PISSN: 01509861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. ADAMSON J, HUMPHRIES SE, OSTERGAARD JR, VOLDBY B, RICHARDS P, POWELL JT. Are Cerebral Aneurysms Atherosclerotic? Stroke 1994; 25: 963-966.
2. ALBERTS MJ, QUINONES A, GRAFFAGNINO C, FRIEDMAN A, ROSES AD. Risk of intracranial aneurysms in families with subarachnoid hemorrhage. Can J Neurol Sci 1995; 22: 121-125.
3. ANDERSON C, MHURCHU CN, SCOTT D, BENNETT D, JAMROZIK K, HANKEY G. Triggers of subarachnoid hemorrhage. Role of physical exertion, smoking, and alcohol in the Australasian cooperative research on subarachnoid hemorrhage study (ACROSS). Stroke 2003; 34: 1771-1776.
4. ASGARI S, WANKE I, SCHOCH B, STOLE D. Recurrent haemorrhage after initially complete occlusion of intracranial aneurysms. Neuroradiology 2003.
5. ATLAS SW, SHEPPARD L, GOLDBERG HI. Intracranial aneurysms: Detection and characterization in a blinded reader study of magnetic resonance angiography using advanced post-processing. Radiology 1997; 203: 807-814.
6. BABA Y, TAKAHASHI M, KOROGI Y. Cost-effectiveness of screening unruptured cerebral aneurysms in Japan. Eur Radiol 2000; 10(S3): S362-S365.
7. BECKER G, PEREZ J, KRONE A. Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery 1992; 31: 420-428.
8. BEDERSON JB, AWAD IA, WIEBERS DO, PIEPGRAS D, HALEY EC, BROTT T, et al. Recommendations for the management of patients with unruptured intracranial aneurysms. A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation 2000; 102: 2300-2308.
9. BLACK WC. Intracranial aneurysm in adult polycystic kidney disease: is screening with MR angiography indicated? Radiology 1994; 191: 18-20.
10. BRILSTRA EH, RINKEL GJE, VAN DER GRAAF Y, VAN ROOIJ WJJ, ALGRA A. Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke 1999; 30: 470-476.
11. BROMBERG JEC, RINKEL GJE, ALGRA A, GREEBE P, VAN DUYN CM, HASAN D, et al. Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. Br Med J 1995; 311: 288-289.
12. BROMBERG JEC, RINKEL GJE, ALGRA A, LIMBURG M, VAN GIJN J. Outcome in familial subarachnoid haemorrhage. Stroke 1995; 26: 961-963.
13. BUTLER WE, BARKER FG, CROWELL RM. Patients with polycystic kidney disease would benefit from routine Magnetic Resonance Angiographic screening for intracerebral aneurysms: a decision analysis. Stroke 1996; 27: 1137-1137.
14. CHAPPELL ET, MOURE FC, GOOD MC. Comparison of Computed Tomographic Angiography with Digital Subtraction Angiography in the diagnosis of cerebral aneurysms: Meta-Analysis. Neurosurgery 2003; 52: 624-631.
15. CHUNG TS, JOO JY, LEE SK, CHIEN D, LAUB G. Evaluation of cerebral aneurysms with high-resolution MR angiography using a section interpolation technique: correlation with digital subtraction angiography. Am J Neuroradiol 1999; 20: 229-235.
16. CLOFT HJ, JOSEPH GJ, DION JE. Meta-analysis of risks of cerebral angiography in patients with subarachnoid hemorrhage, intracranial aneurysm and arteriovenous malformation. Stroke 1999; 30: 317-320.
17. CRAWLEY F, CLIFTON A, BROWN M. Should we screen for Familial Intracranial Aneurysm? Stroke 1999; 30: 312-316.
18. DE BRAEKELEER M, PERUSSE L, CANTIN L, BOUCHARD J-M, MATHIEU J. A study of inbreeding and kinship in intracranial aneurysms in the Saguenay-Lac St-Jean regio (Quebec, Canada). Ann Hum Genet 1996; 60: 99-104.
19. FOGELHOLM R, HERNESNIEMI JA, VAPALAHTI M. Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage: a population-based study. Stroke 1993; 24: 1649-1654.
20. GAIST D, VAETH M, TSIROPOULOS I, CHRISTENSEN K, CORDER E, OLSEN J, SORENSEN HT. Risk of subarachnoid haemorrhage in first-degree relatives of patients with subarachnoid haemorrhage: Follow up study based on national registries in Denmark. Br Med J 2000; 320: 141-145.
21. GUGLIELMI G, VINUELA F, DION J, et al. Electrothrombosis of saccular aneurysms via endovascular approach: Part II. Preliminary clinical experience. J Neurosurg 1991; 75: 8-14.
22. HIJDRA A, BRAAKMAN R, VAN GIJN J, VERMEULEN M, VAN CREVEL H. Aneurysmal subarachnoid haemorrhage: complications and outcome in a hospital population. Stroke 1987; 18: 1061-1067.
23. HOP J, RINKEL GJE, ALGRA A, VAN GIJN J. Case-fatality rates and functional outcome after subarachnoid hemorrhage- a systematic review. Stroke 1997; 28: 660-664.
24. HUGHES R, CHAPMAN A, RUBINSTEIN D, STEARS J, JOHNSON A, GABOW P. Recurrent intracranial aneurysms in autosomal dominant polycystic kidney disease (ADPKD). Stroke 1996; 27(1): 178-178.
25. INTERNATIONAL STUDY OF UNRUPTURED INTRACRANIAL ANEURYSMS (ISUIA) INVESTIGATORS. Factors related to the development and detection of single versus multiple unruptured intracranial aneurysms. Stroke 1996; 27(1): 178-178.
26. INTERNATIONAL STUDY OF UNRUPTURED INTRACRANIAL ANEURYSMS (ISUIA) INVESTIGATORS. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. N Engl J Med 1998; 339: 1725-1733.
27. INTERNATIONAL STUDY OF UNRUPTURED INTRACRANIAL ANEURYSMS (ISUIA) INVESTIGATORS. Unruptured intracranial aneurysms: natural history, clinical outcome and risks of surgical and endovascular treatment. Lancet 2003:
28. INTERNATIONAL SUBARACHNOID ANEURYSM TRIAL (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured aneurysms: a randomised trial. ISAT Collaborative Group. Lancet 2002; 360: 1267-1274.
29. JAGER HR, MANSMANN U, HAUSMANN O, PARTZSCH U, MOSELEY IF, TAYLOR WJ. MRA versus digital subtraction angiography in acute subarachnoid haemorrhage: a blinded multireader study of prospectively recruited patients. Neuroradiology 2000; 42: 313-326.
30. JOHNSTON SC, COLFORD JM, GRESS DR. Oral contraceptives and the risk of subarachnoid hemorrhage - A meta-analysis. Neurology 1998; 51: 411-418.
31. JOHNSTON SC. Effect of endovascular services and hospital volumes on cerebral aneurysm treatment outcomes. Stroke 2000; 31: 111-117.
32. JUVELA S, PORRAS M, HEISKANEN O. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. J Neurosurg 1993; 79: 174-182.
33. JUVELA S. Aspirin and delayed cerebral ischaemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 1995; 82: 945-952.
34. KALLMES DF, KALLMES MH, CLOFT HJ, DION JE. Guglielmi detachable coil embolization for unruptured aneurysms in nonsurgical candidates: a cost-effectiveness exploration. Am J Neuroradiol 1998; 19: 167-176.
35. KING JT, GLICK HA, MASON TJ, FLAMM ES. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J Neurosurg 1995; 83: 403-412.
36. KOJIMA M, NAGASAWA S, LEE YE, TAKEICHI Y, TSUDA E, MABUCHI N. Asymptomatic familial cerebral aneurysms. Neuroimag Clin N Am 1998; 43: 776-781.
37. LANCET EDITORIAL: The screening muddle. Lancet 1998; 351: 459-459.
38. LEBLANC R, LOZANO AM, VAN DER REST M. Absence of collagen deficiency in familial cerebral aneurysms. J Neurosurg 1989; 70: 837-840.
39. LEBLANC R, WORSLEY KJ, MELANSON D, TAMPIERI D. Angiographic screening and elective surgery of familial cerebral aneurysms: a decision-analysis. Neurosurgery 1994; 35: 9-18.
40. LEBLANC R. Familial cerebral aneurysms. Can J Neurol Sc 1997; 24: 191-199.
41. LETTER. Connolly ES, Mohr JP. N Engl J Med 1999; 340: 1439-1440.
42. LINN FHH, RINKEL GJE, ALGRA A, VAN GIJN J. Incidence of subarachnoid haemorrhage. Role of region, year and rate of computed tomography: a meta-analysis. Stroke 1996; 27: 625-629.
43. LOZANO AM, LEBLANC R. Familial intracranial aneurysms. J Neurosurg 1987; 66: 522-528.
44. MALLOUHI A, FELBER S, CHEMELLI A, DESSI S, AUER A, SCHOCKE M et al. Detection and characterization of intracranial aneurysms with MR angiography: comparison of volume-rendering and maximum-intensity-projection algorithms. Am J Roentgenol 2003; 180: 55-64.
45. MARS STUDY GROUP. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid haemorrhage. N Eng J Med 1999; 341: 1344-1350.
46. MCDONALD IG, DALY J, JELINEK VM, PANETTA F, GUTMAN JM. Opening Pandora's box: the unpredictability of reassurance by a normal test result. Br Med J 1996; 313: 329-332.
47. METENS T, RIO M, BALERIAUX D, ROGER T, DAVID P, RODESCH G. Intracranial aneurysms: detection with gadolinium-enhanced dynamic three-dimensional MR Angiography - initial results. Radiology 2000; 216: 39-46.
48. MOROOKA Y, WAGA S. Cerebral aneurysms associated with neurofibromatosis. Surg Neurol 1991; 19: 260-262.
49. MULVIHILL JJ, PARRY DM, SHERMAN JL. Neurofibromatosis 1(Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). Ann Int Med 1990; 113: 39-52.
50. MUNYER TP, MARGULIS AR. Pseudoxanthoma elasticum with internal carotid artery aneurysm. Am J Roentgenol 1981; 136: 1023-1024.
51. NORRGARD O, ANGQUIST K, FODSTAD H, FORSELL A, LIMBURG M. Intracranial aneurysms and heredity. Neurosurgery 1987; 20: 236-239.
52. NORRGARD O, BECKMAN G, BECKMAN L. Genetic markers in patients with intracranial aneurysms. Hum Hered 1987; 37: 255-259.
53. O'BRIEN JG. Subarachnoid haemorrhage in identical twins. Br Med J 1942; 1: 607-608.
54. OBUCHOWSKI NA, MODIC MT, MAGDINEC M. Current implications for the efficacy of noninvasive screening for occult intracranial aneurysms in patients with a family history of aneurysms. J Neurosurg 1995; 83: 42-49.
55. OKAHARA M, KIYOSUE H, YAMASHITA M, NAGATOMI H, HATA H, SAGINOYA T et al. Diagnostic accuracy of Magnetic Resonance Angiography for cerebral aneurysms in correlation with 3D-Digital Subtraction Angiogrpahic Images - a study of 133 aneurysms. Stroke 2002; 33: 1803-1808.
56. OKAMOTO K, HORISAWA R, KAWAMURA T, ASAI A, OGINO M, TAKAGI T et al. Family history and risk of subarachnoid hemorrhage. A case-control study in Nagoya, Japan. Stroke 2003; 34: 422-426.
57. OSTERGAARD JR, HOG E. Incidence of multiple intracranial aneurysms: influence of arterial hypertension and gender. J Neurosurg 1985; 63: 49-55.
58. OYESIKU NM, COLOHAN AR, BARROW DL, REISNER A. Cocaine-induced aneurysmal rupture: an emergent factor in the natural history of intracranial aneurysms? Neurosurgery 1993; 32: 518-526.
59. PEDERSEN HK, BAKKE SJ, HALD JK, SKALPE IO, ANKE IM, SAGSVEEN R et al. CTA in patients with acute subarachnoid haemorrhage. Acta Radiol 2001; 42: 43-49
60. WHITE PM, TEASDALE EM, WARDLAW JM, EASTON V. What is the most sensitive non-invasive imaging strategy for intracranial aneurysms? - J Neurol Neurosurg Psychiatry 2001; 71: 322-328.
61. RAAYMAKERS TWM, RINKEL GJE, LIMBURG M, ALGRA A. Mortality and Morbidity of Surgery for Unruptured Intracranial Aneurysms. Stroke 1998; 29: 1531-1538.
62. RAYMOND J, GUILBERT F, WEILL A, GEORGANOS SA, JURAVSKY L, LAMBERT A et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 2003; 34: 1398-1403.
63. RINKEL GJE, DJIBUTI M, ALGRA A., VAN GIJN J. Prevalence and risk of rupture of intracranial aneurysms. A systematic review. Stroke 1998; 29: 251-256.
64. RINKEL GJE, PRINS NEM, ALGRA A. Outcome of aneurysmal subarachnoid haemorrhage in patients on oral anticoagulant treatment. Stroke 1997; 28: 6-9.
65. ROMAN G, FISHER M, PERL DP, POSER CM. Neurological manifestations of hereditary hemorrhagic telangiectasias (Rendu-Osler-Weber disease): report of two cases and review of the literature. Ann Neurol 1978; 4: 130-144.
66. RONKAINEN A, HERNESNIEMI JA, PURANEN M, NIEMITUKIA L, VANNINEN R, RYYNANEN M, et al. Familial intracranial aneurysms. Lancet 1997; 349: 380-384.
67. RONKAINEN A, MIETTINEN H, KARKOLA K, PAPINAHO S, VANNINEN R, PURANEN M, et al. Risk of harboring an unruptured intracranial aneurysm. Stroke 1998; 29: 359-362.
68. RONKAINEN A, PURANEN M, HERNESNIEMI JA, VANNINEN R, PARTANEN PLK, SAARI JT, et al. Intracranial aneurysms: MR Angiographic screening in 400 asymptomatic individuals with increased familial risk. Radiology 1995; 195: 35-40.
69. Ross JS, MASARYK TJ, MODIC MT, RUGGIERI PM, HAACKE EM, SELMAN WR. Intracranial aneurysms: evaluation by MR angiography. Am J Neuroradiol 1990; 11: 449-456.
70. RUGGIERI PM, POULOS N, MASARYK TJ, ROSS JS, OBUCHOWSKI NA, AWAD IA, et al. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 1994; 191: 33-39.
71. SCHIEVINK WI, DE WAAL LP, HAGEMAN LM. Intracranial aneurysm and HLA-DR2. J Neurol Neurosurg Psychiatry 1988; 51: 883.
72. SCHIEVINK WI, KAREMAKER JM, HAGEMAN LM. Circumstances surrounding subarachnoid hemorrhage. Surg Neurol 1989; 32: 266-272.
73. SCHIEVINK WI, KATZMANN JA, PIEPGRAS DG. Alpha-1-antitrypsin phenotype among patients with intracranial aneurysms. J Neurosurg 1996; 84: 781-784.
74. SCHIEVINK WI, LIMBURG M, DREISSEN JJR. Screening for unruptured familial intracranial aneurysms: subarachnoid hemorrhage 2 years after angiography negative for aneurysms. Neurosurgery 1991; 29: 434-438.
75. SCHIEVINK WI, LIMBURG M, OORTHUYS JWE, FLEURY P, POPE FM. Cerebrovascular disease in Ehlers-Danlos syndrome type IV. Stroke 1990; 21: 626-632.
76. SCHIEVINK WI, SCHAID DJ, MICHELS VV, PIEPGRAS DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg 1995; 83: 426-429.
77. SENGUPTA RP, MCALLISTER VL. Subarachnoid haemorrhage. Berlin: Springer-Verlag; 1986.
78. SUZUKI M, MATSUI O, UEDA F, HATTORI Y, MINAMI T, KOBAYASHI K et al. contrast-enhanced MR angiography (enhanced 3-D fast gradient echo) for diagnosis of cerebral aneurysms. Neuroradiology 2003; 44: 17-20.
79. TER BERG HWM, DIPPEL D, HABBEMA J, BIJLSMA JB, VAN GIJN J, TULLEKEN CAF, et al. Treatment of intact familial intracranial aneurysms: a decision-analytical approach. Neurosurgery 1988; 23: 329-334.
80. TER BERG HWM, DIPPEL DWJ, LIMBURG M, SCHIEVINK WI, VAN GIJN J. Familial intracranial aneurysms: a review. Stroke 1992; 23: 1024-1030.
81. TEUNISSEN LL, RINKEL GJE, ALGRA A, VAN GIJN J. Risk factors for subarachnoid haemorrhage: a systematic review. Stroke 1996; 27: 544-549.
82. TSUCHIYA T, YASAKA M, YAMAGUCHI T. Imaging of the basal cerebral arteries and measurement of blood velocity in adults using transcranial real-time color flow Doppler sonography. Am J Neuroradiol 1991; 12: 497-502.
83. TURNER CL, KIRKPATRICK PJ. Detection of intracranial aneurysms with unenhanced and echo contrast enhanced transcranial power Doppler. J Neurol Neurosurg Psychiatry 2000; 68: 489-495.
84. VAN DEN BERG JSP, LIMBURG M, HENNEKAM RCM, CRUYSBERG JRM, STEIJILEN PM, LIMBURG M. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum. Cerebrovasc Dis 1999; 9(S1): 3.
85. VAN DEN BERG JSP, LIMBURG M, HENNEKAM RCM. Is Marfan syndrome associated with symptomatic intracranial aneurysms? Stroke 1996; 27: 10-12.
86. VAN GIJN J. What has caused this subarachnoid haemorrhage? In: Warlow CP, Dennis MS, van Gijn J, Hankey GJ, Sandercock PAG, Bamford JM, Wardlaw JM, editors. Stroke, a practical guide to management. Oxford: Blackwell Science; 1996. p 322-359.
87. VINUELA F, DUCKWILER G, MAWAD M. Guglielmi detachable coil embolisation of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997; 86: 475-482.
88. WANG P, LONGSTRETH WT, KOEPSELL TD. Subarachnoid hemorrhage and family history: a population based case-control study. Arch Neurol 1995; 52: 202-204.
89. WARDLAW JM on behalf of Davie Cooper Study Investigators. Familial risk of subarachnoid haemorrhage in the Scottish population. Neuroradiology 2001; 43: 415-416. [full results in press]
90. WARDLAW JM, CANNON J. Color transcranial "power" Doppler ultrasound of intracranial aneurysms. J Neurosurg 1996; 84: 459-461.
91. WARDLAW JM, WHITE PM. The detection and management of unruptured intracranial aneurysms. Brain 2000; 123: 205-221.
92. WHITE PM, TEASDALE EM, WARDLAW JM, EASTON V. CTA and MRA in the detection of intracranial aneurysms: a prospective, blinded comparison in a large patient cohort. Radiology 2001; 219: 739-746.
93. WHITE PM, TEASDALE EM, WARDLAW JM, LINDSAY KW, SLOSS S, PATEL D. The non-invasive detection of intracranial aneurysms: do neuroradiologists do it better? Eur Radiol 2003; 13: 389-396.
94. WHITE PM, WARDLAW JM, EASTON V. Can non-invasive imaging tests accurately depict intracranial aneurysms? A systematic review. Radiology 2000; 217: 361-370.
95. WHITE PM, WARDLAW JM, TEASDALE E, SLOSS S, CANNON J, EASTON V. Power Transcranial Doppler Ultrasound in the detection of intracranial aneurysms. Stroke 2001; 32: 1291-1297,
96. WIEBERS DO, TORRES VE. Screening for unruptured intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med 1992; 327: 953-955.
97. WIEBERS DO, WHISNANT JP, SUNDT TM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987; 66: 23-29.
98. YOSHIMOTO Y, WAKAI S. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms. A mathematical model. Stroke 1999; 30: 1621-1627.